Sex & Infertility Expert: You Need To Grow Your Sex Span! This Is Killing Your Fertility! This Daily Habit Transforms Your Sex Life!

Episode Summary

Executive Summary: The episode explores “sexpan” (sexual lifespan) with urologist Dr. Mohit Khera, arguing that sexual dysfunction is common, treatable, and often an early warning sign of broader health problems. He frames sexual health as a couple’s issue shaped by hormones, lifestyle, psychology, and relationship dynamics, and emphasizes diet, exercise, sleep, stress reduction, and targeted therapies as ways to improve libido, erections, fertility, and long-term sexual function.

Main Topics: Sexpan and the four pillars of sexual health (Priority: 5/5): Dr. Khera introduces sexpan as the period of satisfying sexual activity and argues it can be prolonged through diet, exercise, sleep, stress reduction, and hormone optimization, while also treating sexual health as a couple-level issue. Erectile dysfunction as a marker of systemic disease (Priority: 5/5): ED is presented not just as a sexual issue but as an early sign of cardiovascular disease, diabetes, depression, and vascular dysfunction, making it a gateway to broader men’s health screening. Libido, hormones, and psychogenic factors (Priority: 5/5): Low libido is described as multifactorial, involving testosterone, prolactin, estrogen, thyroid, neurotransmitters, medications, fatigue, stress, relationship quality, and anxiety-driven performance issues. Treatment options for men: lifestyle, PDE5 inhibitors, testosterone, and procedures (Priority: 5/5): The discussion covers daily Cialis, testosterone replacement or testosterone-boosting medications, exercise and diet interventions, and advanced options like injections, shockwave therapy, and penile implants. Female sexual dysfunction and the treatment gap (Priority: 4/5): Dr. Khera highlights that women often suffer in silence, with limited FDA-approved options, and explains the four components of female sexual dysfunction plus off-label hormone and medication strategies. Pornography, modern behavior, and declining sexual activity (Priority: 4/5): The episode links rising pornography use, virtual socialization, obesity, diabetes, and sedentary lifestyles to worsening sexual function and reduced partnered sex, while noting the evidence is mixed on porn’s direct causal role. Fertility, testosterone decline, and prevention (Priority: 4/5): The conversation connects declining testosterone and sperm counts to obesity and metabolic health, emphasizing semen analysis, weight loss, and early intervention as fertility-preserving strategies.

Key Arguments: Sexual dysfunction is common, under-discussed, and often curable; people should seek help rather than suffer in silence. Sexpan can be prolonged by the same fundamentals that improve lifespan and healthspan: diet, exercise, sleep, and stress reduction. ED is frequently an early warning sign of cardiovascular disease and metabolic illness, so it should trigger medical evaluation. Low testosterone contributes to low libido, erectile dysfunction, mood issues, body composition changes, and fertility problems in both men and women. Daily Cialis is argued to be more than a band-aid because it may improve penile tissue health and endothelial function over time. Women are significantly underserved in sexual medicine, with far fewer approved treatments than men and a major research gap. Pornography may worsen sexual function for some men by creating a gap between expectation and reality, especially when used excessively. Sexual dysfunction is often a couple’s problem; treating only one partner can worsen relationship dynamics. Lifestyle changes can materially improve sexual function, with diet, sleep, and exercise showing measurable benefits in studies. Advanced interventions such as shockwave therapy, PRP, stem cells, and penile implants are emerging or established options for refractory cases.

Data Points: U.S. average lifespan: 77 years - Used to explain the gap between lifespan, healthspan, and sexpan. U.S. average healthspan: 67 years - Presented as the average period of healthy living before disability. CDC disability-free lifespan: 63 years - Cited to show that many people spend years with reduced function. Female sexual dysfunction prevalence in the U.S.: 43% to 48% - Dr. Khera says this affects women across four components of sexual function. Premature ejaculation prevalence globally: 30% - Used to show how common male sexual dysfunction is worldwide. Erectile dysfunction prevalence at age 40: 40% - Framed as a common condition and an early health warning sign. Men with ED who have depression: 66% - Used to emphasize the mental health overlap with ED. Men with ED who will have heart attack or stroke within 7 years: 15% - Presented as evidence ED can predict future cardiovascular events. Men with ED and occult heart disease in a Greek study: 20% - Among 50 men evaluated, one in five had coronary occlusion. Average male ejaculation time: 5.4 minutes - Compared with average female orgasm time to discuss premature ejaculation. Average time for women to achieve orgasm: 13.4 minutes - Used to highlight the orgasm timing gap in heterosexual sex. Women seeking therapy for sexual dysfunction: 19% - Shows the treatment gap for female sexual dysfunction. Men seeking therapy for premature ejaculation: 9% - Indicates low help-seeking despite high prevalence. Men with ED who do not tell partners: 44% - Used in the discussion of communication and avoidance. Men with ED who have undiagnosed diabetes: 2x more likely - ED is described as a screening opportunity for diabetes. Diabetics’ ED risk: 4x higher - Diabetes is described as the strongest risk factor for ED. Obesity-related testosterone decline: ~300 ng/dL decline over decades - Average testosterone fell from the 700s to the mid-400s in cited studies. Testosterone increase with 10% weight loss: +85 ng/dL - From the European Male Aging Study, showing weight loss can raise testosterone. Testosterone increase with 15% weight loss: +250 ng/dL - Shows a larger effect with greater weight loss. Exercise dose linked to improved erectile function: 160 minutes/week - Moderate-to-vigorous exercise for about six months improved ED. Sleep threshold linked to sexual dysfunction: <6 hours/night - Less than six hours was associated with higher sexual dysfunction risk. Ideal sleep range: 7 to 8 hours/night - Presented as optimal for sexual function. Men with low sperm counts and future diabetes risk: 30% increased risk - Cited as evidence semen quality predicts broader health. Men with low sperm counts and future ischemic heart disease risk: 50% increased risk - Used to argue semen analysis is a health marker. Men with low sperm counts and high-grade prostate cancer risk: 2.5x higher risk - Another example of semen analysis predicting future disease. TRAVERSE trial size: 5,200 patients - Largest randomized placebo-controlled testosterone safety trial described. TRAVERSE trial duration: 6 years - Used to emphasize the strength of the evidence. TRAVERSE trial outcome: No significant increase in cardiovascular events - Presented as reassurance about testosterone therapy safety. TRAVERSE trial outcome on prostate cancer: No increase - Addressed a major historical concern about testosterone. TRAVERSE trial outcome on urinary symptoms: No worsening - Another common concern addressed by the trial. Penile prosthesis satisfaction: >92% - Reported satisfaction for both patient and partner. Peyronie’s disease prevalence: 9% of men - Described as a common but underrecognized cause of penile curvature. Postpartum female sexual problems: Over 80% at 3 months; nearly two-thirds at 6 months - Cited to show childbirth’s impact on sexual function. No FDA-approved drugs for women in 2015: 0 - Used to highlight the treatment gap for female sexual dysfunction. First FDA-approved drug for female sexual dysfunction: 2015 - Flibanserin (Addyi) was described as the first approved option.

Pivotal Quotes: "Sexpan is the ability to engage in satisfying sexual activity." — Dr. Mohit Khera: Defines the central concept of the episode and frames sexual health as a lifespan issue. "ED is the gateway to men's health and to treating men early before it's too late." — Dr. Mohit Khera: Explains why erectile dysfunction should trigger broader medical screening. "It's okay to suffer from sexual dysfunction. It's normal as we age and there are many treatment options good treatment options that can help you today." — Dr. Mohit Khera: Closing message aimed at reducing stigma and encouraging treatment-seeking.

Implications: Listeners should treat sexual dysfunction as a medical and relational issue, not a personal failure. The field is moving toward prevention, hormone optimization, and regenerative therapies, while better education and destigmatization could improve outcomes for couples and overall health.